Scientific News What Makes Boston Scientific Corporation Bsx A Compelling Investment
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News What Makes Boston Scientific Corporation Bsx A Compelling Investment is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?
Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More
What Makes Boston Scientific Corporation (BSX) an Investment Choice?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market continued ... Read More
Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX)
Boston Scientific Corporation (NYSE:BSX) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 23, William Plovanic from Canaccord Genuity reiterated a Buy rating on Boston ... Read More
Boston Scientific: Q3 Earnings Snapshot
Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the ... Read More
Boston Scientific Corporation Is Expensive But Worth It
Boston Scientific is a 'forever stock' due to management foresight, robust R&D, and leadership in AI-driven medical devices. Despite a weak valuation grade, its strong financials, global expansion, ... Read More
Do You Believe in the Growth Trajectory of Boston Scientific Corporation (BSX)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first ... Read More
Algert Global LLC Sells 1,330 Shares of Boston Scientific Corporation $BSX
Algert Global LLC reduced its position in shares of Boston Scientific Corporation (NYSE:BSX – Free Report) by 39.9% in the first quarter, according to the company in its most recent filing with the ... Read More
Advisors Capital Management LLC Acquires 948 Shares of Boston Scientific Corporation $BSX
Advisors Capital Management LLC grew its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 27.5% during the 1st quarter, according to the company in its most recent filing with the ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus